21478 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
LABELING REACTANT
#302Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
#303Sensors for fluorescence and magnetic resonance imaging
#304Thyroid hormone analogs and methods of use
#305Imaging Cellular Nucleic Acids
#306SYSTEMS AND METHODS FOR HIGH-RESOLUTION IN VIVO IMAGING OF BIOCHEMICAL ACTIVITY IN A LIVING ORGANISM
#307Flexibly labeling peptides
#308Methods and Compositions for Imaging and Biomedical Applications
#309Gastrin Releasing Peptide Compounds
#310Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease
#311Nanoparticles and their use for multifunctional bioimaging
#312Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
#313NOVEL NANOPARTICLES AND USE THEREOF
#314Optically pure and enriched isomers of chelating ligands and contrast agents
#315Targeted MR imaging agents
#316Peptide conjugates
#317Contrast agents for magnetic resonance imaging
#318Compositions and methods for enhancing drug delivery across and into ocular tissues
#319Peptide-Based Multimeric Targeted Contrast Agents
#320Compositions and methods for enhancing drug delivery across and into epithelial tissues
#321Neutral labeling reactants and conjugates derived thereof
#322Polymeric imaging agents and medical imaging methods
#323Labeling reactant
#324Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy
#325Conjugated macromolecules
#326Optimized relaxivity and specificity hepatobiliary MRI contrast agent
#327Liposomes useful for drug delivery to the brain
#328Magnetic resonance imaging contrast agents
#329Guanidinium delivery carriers
#330Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
#331Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
#332Radiopharmaceuticals for cancer diagnosis and treatment
#333Peptides whose uptake by cells is controllable
#334Stationary target imaging
#335Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications
#336Diagnostic imaging contrast agents with extended blood retention
#337Diagnostic imaging contrast agents with extended blood retention
#338Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy
#339Hydrazide conjugates as imaging agents
#340Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
#341Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules
#342Diagnostic imaging contrast agents with extended blood retention
#343Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis
#344Chemical exchange saturation transfer contrast agents
#345Bioactivated diagnostic imaging contrast agents
#346Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilones
#347Lectin conjugates
#348Specific high-relaxivity compounds
#349Gastrin releasing peptide compounds
#350Peptide conjugate for magnetic resonance imaging
#351VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment
#352Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and NSconjugates for MR contrast media and radiopharmaceuticals
#353Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent
#354Optically pure and enriched isomers of chelating ligands and contrast agents
#355Trimeric, macrocyclically substituted halo-benzene derivatives
#356MRI contrast agents
#357Method for assessing tumor response to cancer treatment
#358Polymeric contrast agents for use in medical imaging
#359Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives
#360Polymerization method for the synthesis of polypeptide imaging agents
#361Method of preselection patients for anti-VEGF, anti-HIF-1 or anti-thioredoxin therapy
#362Galenical formulations
#363Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase
#364Contrast enhancement agent for magnetic resonance imaging
#365Compositions for detecting hyaluronidase activity in situ and methods of utilizing same
#366Method for convection enhanced delivery of therapeutic agents
#367Enhanced ligand binding to neurotensin receptors
#368Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents
#369Peptides whose uptake by cells is controllable
#370Peptide-based multimeric targeted contrast agents
#371Blood brain barrier permeation peptides
#372Galactopyrannosyltriaminetetracarboxylate as ligands for bioactivated paramagnetic metal complexes
#373Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#374Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells
#375Porphyrin compounds and their use in high-field MRI
#376Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gbexpressing tumors
#377Lipophilic derivatives of chelate monoamides
#378Matrix metalloproteinase inhibitors
#379Imaging damaged lung tissue using compositions
#380Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
#381Biochemically-activated contrast agents for magnetic resonance imaging
#382Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
#383Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage
#384Agents for magnetic imaging method
#385Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
#386Polybiotin compounds for magnetic resonance imaging and drug delivery
#387Fluorinated carbohydrate conjugates
#388Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
#389Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
#390Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
#391DNA-dependent MRI contrast agents
#392Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
#393Peptide-based multimeric targeted contrast agents
#394Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
#395Methods of cardiothoracic imaging - (MET-30)
#396Matrix metalloproteinase inhibitors
#397Target-specific activatable polymeric imaging agents
#398Matrix metalloproteinase inhibitors
#399Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
#400Hydroxypyridonate and hydroxypyrimidinone chelating agents
#401Magnetic resonance imaging agents for the detection of physiological agents
#402COX-2-targeted imaging agents
#403Pharmaceutical composition with nanoparticle-based drug delivery combined with non-invasive radiographic monitoring model